Elsbet Pieterman

3.2k citations

57 papers · 2.6k indexed · h-index 26

Rheumatology top 2%
Oncology top 5%
- CAR-T cell therapy research 4
Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases 6
Orthopedics and Sports Medicine top 5%
Environmental Chemistry top 5%
Surgery
- Lipoproteins and Cardiovascular Health 16
- Cholesterol and Lipid Metabolism 7
Epidemiology
- Liver Disease Diagnosis and Treatment 7
Genetics
- Virus-based gene therapy research 4
Cancer Research
- Cancer, Lipids, and Metabolism 4
Endocrinology, Diabetes and Metabolism
- Diet, Metabolism, and Disease 4

Co-authors: Louis Cohen Socrates E. Papapoulos Clemens W.G.M. Löwik Ermond van Beek P. Hans T. Huizinga J. Wouter Jukema José W.A. van der Hoorn
Cited by: Rheumatology Oncology Immunology
Journals: Journal of Biological Chemistry (1 paper)PLoS ONE (2 papers)The FASEB Journal (1 paper)
Partner nations: Netherlands United States Sweden

In The Last Decade

Elsbet Pieterman

55 papers receiving 2.5k citations

Peers

Countries citing papers authored by Elsbet Pieterman

Since Specialization

Citations

This map shows the geographic impact of Elsbet Pieterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsbet Pieterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsbet Pieterman more than expected).

Fields of papers citing papers by Elsbet Pieterman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsbet Pieterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsbet Pieterman. The network helps show where Elsbet Pieterman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Elsbet Pieterman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elsbet Pieterman Line = papers co-authored together Elsbet Pieterman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL-clearance and regress atherosclerosis on atorvastatin background Journal of Lipid Research ·José A. Inia,Leo H. Zhang,Nanda Keijzer,Nicole Worms,Anita van Nieuwkoop-van Straalen,Marc Ditmarsch,Mathijs de Kleer,J. Wouter Jukema,J Kastelein,M Szarek,Anita M. van den Hoek,Geurt Stokman,Elsbet Pieterman,H. Princen	2026	0
2	Effects of life-long hyperlipidaemia on age-dependent development of endothelial dysfunction in humanised dyslipidaemic mice GeroScience ·Anna Bar,Piotr Berkowicz,Anna Kurpińska,Tasnim Mohaissen,Agnieszka Karaś,Patrycja Kaczara,Joanna Suraj,Magdalena Sternak,Brygida Marczyk,Agata Malinowska,Agnieszka Kij,Agnieszka Jasztal,Izabela Czyżyńska-Cichoń,Elsbet Pieterman,P. Hans,Jacek R. Wiśniewski,Stefan Chłopicki	2025	0
3	Intensive cholesterol-lowering treatment reduces synovial inflammation during early collagenase-induced osteoarthritis, but not pathology at end-stage disease in female dyslipidemic E3L.CETP mice Osteoarthritis and Cartilage ·Y. van Gemert,Arjen B. Blom,Irene Di Ceglie,Birgitte Walgreen,M.M. Helsen,A. Sloëtjes,Thomas Vogl,Johannes Roth,N.N.L. Kruisbergen,Elsbet Pieterman,P. Hans,P.M. van der Kraan,Peter L. E. M. van Lent,Martijn H. J. van den Bosch	2023	3
4	Differential effects of plant and animal fats on obesity‐induced dyslipidemia and atherosclerosis in Ldlr−/−.Leiden mice The FASEB Journal ·Martine C. Morrison,Bjørg Egelandsdal,Silje Harvei,Sérgio D.C. Rocha,Elsbet Pieterman,Robert Kleemann,Harald Carlsen	2023	4
5	Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE3-Leiden Mice by Reducing Hepatic Inflammation International Journal of Molecular Sciences* ·José A. Inia,Geurt Stokman,Elsbet Pieterman,Martine C. Morrison,Aswin Menke,Lars Verschuren,Martien P. M. Caspers,Martin Giera,J. Wouter Jukema,Anita M. van den Hoek,P. Hans	2023	12
6	Proof-of-concept study for liver-directed miQURE technology in a dyslipidemic mouse model Molecular Therapy — Nucleic Acids ·Vanessa Zancanella,Astrid Vallès,Jolanda M.P. Liefhebber,Lieke Paerels,Carlos Vendrell Tornero,Hendrina Wattimury,Tom van der Zon,Kristel van Rooijen,Monika Golinska,Tamar Grevelink,Erich Ehlert,Elsbet Pieterman,Nanda Keijzer,P. Hans,Geurt Stokman,Ying Poi Liu	2023	3
7	The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis British Journal of Pharmacology ·Miguel Carracedo,Sven‐Christian Pawelzik,Gonzalo Artiach,Marianne Pouwer,Oscar Plunde,Peter Saliba‐Gustafsson,Ewa Ehrenborg,Per Eriksson,Elsbet Pieterman,Leif Stenke,P. Hans,Anders Franco‐Cereceda,Magnus Bäck	2022	9
8	A Novel, Orally Bioavailable, Small-Molecule Inhibitor of PCSK9 With Significant Cholesterol-Lowering Properties In Vivo Journal of Lipid Research ·Alexandra K. Suchowerska,Geurt Stokman,James T. Palmer,Phillip A. Coghlan,Elsbet Pieterman,Nanda Keijzer,Gilles Lambert,Kévin Chemello,Ali K. Jaafar,Jasneet Parmar,Liping Yan,Yingtao Tong,Lin Mu,P. Hans,J. Bonnar,Benny J. Evison	2022	15
9	Effects of mineral oil administration on the pharmacokinetics, metabolism and pharmacodynamics of atorvastatin and pravastatin in mice and dogs European Journal of Pharmaceutical Sciences ·V. Sashi Gopaul,Elsbet Pieterman,P. Hans,Linnéa Bergenholm,Eva Lundborg,Anders Cavallin,Magnus J. Johansson,Glen Hawthorne,Anders Björkbom,Maria Hammarberg,Xueqing Li,Annica Jarke,Jonathan Bright,Lena Svensson,Rasmus Jansson‐Löfmark,Bertil Abrahamsson,Rahul Agrawal,Eva Hurt‐Camejo	2021	10
10	Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative Liver International ·Geurt Stokman,Anita M. van den Hoek,Ditte Denker Thorbekk,Elsbet Pieterman,Sanne Skovgård Veidal,Brittany Basta,Marta Iruarrizaga‐Lejarreta,José W. van der Hoorn,Lars Verschuren,Jimmy F.P. Berbée,Patrick C.N. Rensen,Tore Skjæret,Cristina Alonso,Michael Feigh,John J.P. Kastelein,Scott L. Friedman,P. Hans,David A. Fraser	2020	15
11	Oncostatin M reduces atherosclerosis development in APOE3Leiden.CETP mice and is associated with increased survival probability in humans PLoS ONE* ·Daniëlle van Keulen,Marianne Pouwer,Valur Emilsson,Ljubica Matic,Elsbet Pieterman,Ulf Hedin,Vilmundur Guðnason,Lori L. Jennings,Kim Holmstrøm,Boye Schnack Nielsen,Gerard Pasterkamp,J. Lindeman,Alain J. van Gool,Maarten D. Sollewijn Gelpke,P. Hans,Dennie Tempel	2019	8
12	The APOE∗3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis Journal of Diabetes Research ·Marianne Pouwer,Suvi E. Heinonen,Margareta Behrendt,Anne‐Christine Andréasson,Arianne van Koppen,Aswin Menke,Elsbet Pieterman,Anita M. van den Hoek,J. Wouter Jukema,Brendan Leighton,Ann‐Cathrine Jönsson‐Rylander,P. Hans	2019	9
13	Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice Journal of Lipid Research ·Marianne Pouwer,Elsbet Pieterman,Nicole Worms,Nanda Keijzer,J. Wouter Jukema,Jesper Gromada,Viktoria Gusarova,P. Hans	2019	52
14	Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE3-Leiden.CETP Mice Toxicological Sciences* ·Marianne Pouwer,Elsbet Pieterman,Shu‐Ching Chang,Geary W. Olsen,Martien P. M. Caspers,Lars Verschuren,J. Wouter Jukema,P. Hans	2019	27
15	Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice Hepatology Communications ·Martine C. Morrison,Lars Verschuren,Kanita Salic,Joanne Verheij,Aswin Menke,Peter Y. Wielinga,Marta Iruarrizaga‐Lejarreta,Laurent Golé,Weimiao Yu,Scott Turner,Martien P. M. Caspers,Ibon Martínez‐Arranz,Elsbet Pieterman,Reinout Stoop,Arianne van Koppen,Anita M. van den Hoek,José M. Mato,Roeland Hanemaaijer,Cristina Alonso,Robert Kleemann	2018	53
16	Osteoarthritis development is induced by increased dietary cholesterol in APOE3Leiden.CETP mice, a translational model for atherosclerosis, and can be inhibited by atorvastatin Osteoarthritis and Cartilage* ·Lobke Gierman,Susan Kühnast,Angela Koudijs,Elsbet Pieterman,M. Kloppenburg,Gerjo J. V. M. van Osch,V. Stojanovic‐Susulic,T. Huizinga,P. Hans,A.‐M. Zuurmond	2013	7
17	A Novel EPO Receptor Agonist Improves Glucose Tolerance via Glucose Uptake in Skeletal Muscle in a Mouse Model of Diabetes Experimental Diabetes Research ·Michael S. Scully,Tatiana Ort,Ian E. James,Peter J. Bugelski,Dorie Makropoulos,Heather Deutsch,Elsbet Pieterman,Anita M. van den Hoek,Louis M. Havekes,William H. duBell,Joshua D. Wertheimer,Kristen Picha	2011	14
18	Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair Genes and Immunity ·Tineke C. T. M. van der Pouw Kraan,F. van Gaalen,T. Huizinga,Elsbet Pieterman,F. C. Breedveld,C L Verweij	2003	112
19	Infection efficiency of type 5 adenoviral vectors in synovial tissue can be enhanced with a type 16 fiber Arthritis & Rheumatism ·Paulien H. Goossens,Menzo Havenga,Elsbet Pieterman,Angelique A. C. Lemckert,Ferdinand C. Breedveld,A. Bout,T. Huizinga	2001	37
20	Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF−308A in systemic lupus erythematosus Genes and Immunity ·Michiel W. van der Linden,Arno R. van der Slik,Eric Zanelli,MJ Giphart,Elsbet Pieterman,GM T h Schreuder,R. Westendorp,T. Huizinga	2001	40

About Elsbet Pieterman

Elsbet Pieterman is a scholar working on Rheumatology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 57 papers that have together received 2.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (16 papers), Cholesterol and Lipid Metabolism (7 papers), Liver Disease Diagnosis and Treatment (7 papers), Atherosclerosis and Cardiovascular Diseases (6 papers), Virus-based gene therapy research (4 papers), CAR-T cell therapy research (4 papers), Cancer, Lipids, and Metabolism (4 papers) and Diet, Metabolism, and Disease (4 papers). The work is most often cited by research in Rheumatology (530 citations), Oncology (714 citations) and Immunology (490 citations). Elsbet Pieterman has collaborated with scholars based in Netherlands, United States and Sweden. Frequent co-authors include Louis Cohen, Socrates E. Papapoulos, Clemens W.G.M. Löwik, Ermond van Beek, P. Hans, T. Huizinga, J. Wouter Jukema, José W.A. van der Hoorn, Marianne Pouwer and Tineke C. T. M. van der Pouw Kraan. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact